Julia M. Ayala
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Chemokine receptors and signaling, Peptidase Inhibition and Analysis, Protease and Inhibitor Mechanisms, Cytokine Signaling Pathways and Interactions, Neuropeptides and Animal Physiology
Most-Cited Works
- → A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes(1992)2,559 cited
- → Activation of the Native 45-kDa Precursor Form of Interleukin-1-converting Enzyme(1996)195 cited
- → Leukotriene B4Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes(2004)141 cited
- → VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.(1995)124 cited
- → IL-1 beta -converting enzyme is present in monocytic cells as an inactive 45-kDa precursor.(1994)114 cited
- → Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells.(1993)112 cited
- → Enzymatically Inactive Macrophage Migration Inhibitory Factor Inhibits Monocyte Chemotaxis and Random Migration(1999)106 cited
- → CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates(2007)65 cited
- → Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum(1995)64 cited
- → Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway(2000)64 cited